IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Patient Square Capital LP

Portfolio Profile

CIK: 0001819257 | MENLO PARK, CA

Investment Profile

Style

Deep Value

Turnover

High

Orientation

Concentrated trader
$645.5M
AUM
23
Positions
80.13%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Roivant Sciences LTD(ROIV)8,020,928$283.9M43.97%
2Revolution Medicines Inc(RVMD)276,000$51.7M8.01%
3Mirum Pharmaceuticals Inc(MIRM)260,500$30.5M4.72%
4Abivax SA(ABVX)206,500$27.5M4.26%
5Beone Medicines LTD(ONC)90,020$25.7M3.97%
6

Sector Allocation

Latest filing, equity positions only

Healthcare52.43% · $338.5M
Unclassified47.57% · $307.1M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare57.39%52.43%-4.96%
Unclassified42.61%47.57%+4.96%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$182.0M | 2 pos.
$182.9M | 2 pos.
$234.8M | 2 pos.
$215.4M | 2 pos.
$269.4M | 11 pos.
$267.4M | 20 pos.
Pharvaris N V(PHVS)
671,209
$23.2M
3.60%
7Argenx SE(ARGX)23,000$21.3M3.31%
8United Therapeutics Corp del(UTHR)37,120$20.1M3.12%
9Belite BIO Inc(BLTE)110,000$16.9M2.62%
10Cogent Biosciences Inc(COGT)425,000$16.4M2.55%
Cap SizePrev %Curr %Change
Unclassified42.61%47.57%+4.96%
Mid Cap30.08%21.89%-8.19%
Large Cap13.57%20.34%+6.77%
Small Cap11.09%8.36%-2.73%
Micro Cap0.95%1.84%+0.89%
Mega Cap1.71%0%-1.71%
$241.7M | 19 pos.
$277.4M | 19 pos.
$373.9M | 24 pos.
$467.1M | 28 pos.
$563.6M | 29 pos.
$645.5M | 23 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

6
New
12
Closed
9
Increased
8
Decreased
0
Unchanged